EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
1.14.15.5 | corticosterone + reduced adrenal ferredoxin + O2 |
- |
Cavia porcellus |
18-hydroxycorticosterone + oxidized adrenal ferredoxin + H2O |
- |
? |
1.14.15.5 | corticosterone + reduced adrenal ferredoxin + O2 |
- |
Homo sapiens |
18-hydroxycorticosterone + oxidized adrenal ferredoxin + H2O |
- |
? |
1.14.15.5 | corticosterone + reduced adrenal ferredoxin + O2 |
- |
Bos taurus |
18-hydroxycorticosterone + oxidized adrenal ferredoxin + H2O |
- |
? |
1.14.15.5 | corticosterone + reduced adrenal ferredoxin + O2 |
- |
Ovis aries |
18-hydroxycorticosterone + oxidized adrenal ferredoxin + H2O |
- |
? |
1.14.15.5 | corticosterone + reduced adrenal ferredoxin + O2 |
reaction in the biosynthesis of aldosterone |
Cavia porcellus |
18-hydroxycorticosterone + oxidized adrenal ferredoxin + H2O |
- |
? |
1.14.15.5 | corticosterone + reduced adrenal ferredoxin + O2 |
reaction in the biosynthesis of aldosterone |
Bos taurus |
18-hydroxycorticosterone + oxidized adrenal ferredoxin + H2O |
- |
? |
1.14.15.5 | corticosterone + reduced adrenal ferredoxin + O2 |
reaction in the biosynthesis of aldosterone |
Ovis aries |
18-hydroxycorticosterone + oxidized adrenal ferredoxin + H2O |
- |
? |
1.14.15.5 | more |
reduced enzyme activity occurs in hyponatremia and hyperkalemia due to an isolated aldosterone biosynthesis defect, the phenotype can be rescued by a fludrocortisone replacement therapy, overview |
Homo sapiens |
? |
- |
? |